Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Supernus Pharmaceuticals
SUPN
$2.45B
| $52.2M | 0.07% |
1,655,322
+69,600
| +4% | +$2.23M |
2017 Q4
30 quarters
|
|
327
PLDT
PHI
$3.95B
| $52M | 0.07% |
2,391,669
-35,399
| -1% | -$799K |
2013 Q2
48 quarters
|
|
328
Root
ROOT
$752M
| $52M | 0.07% |
406,315
-13,200
| -3% | -$1.79M |
2021 Q4
14 quarters
|
|
329
Petrobras Class A
PBR.A
$143B
| $51.8M | 0.07% |
4,488,000
+615,100
| +16% | +$6.85M |
2018 Q2
28 quarters
|
|
330
United Parcel Service
UPS
$80.1B
| $51.5M | 0.07% |
+510,500
| New | +$50.2M |
2025 Q2
0 quarters
|
|
331
Vanguard Tax-Exempt Bond Index Fund
VTEB
$44.2B
| $51.5M | 0.07% |
1,050,800
+775,900
| +282% | +$37.9M |
2022 Q4
10 quarters
|
|
332
Qualys
QLYS
$6.71B
| $51.5M | 0.07% |
360,400
-21,900
| -6% | -$2.9M |
2021 Q3
15 quarters
|
|
333
Skywest
SKYW
$3.76B
| $51.3M | 0.07% |
498,024
-41,200
| -8% | -$3.92M |
2014 Q4
42 quarters
|
|
334
Okta
OKTA
$38.5B
| $51M | 0.07% |
510,618
+282,203
| +124% | +$30.1M |
2022 Q1
13 quarters
|
|
335
Takeda Pharmaceutical
TAK
$59.2B
| $51M | 0.07% |
3,299,200
+141,500
| +4% | +$2.09M |
2019 Q2
24 quarters
|
|
336
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.06B
| $50.8M | 0.07% |
1,646,900
-168,700
| -9% | -$5.18M |
2021 Q4
14 quarters
|
|
337
British American Tobacco
BTI
$119B
| $50.7M | 0.07% |
1,070,499
+899,000
| +524% | +$39.8M |
2025 Q1
1 quarter
|
|
338
Otis Worldwide
OTIS
$25.2B
| $50.6M | 0.07% |
+511,200
| New | +$49.3M |
2025 Q2
0 quarters
|
|
339
Datadog
DDOG
$98.3B
| $50.5M | 0.07% |
376,252
-784,100
| -68% | -$86.8M |
2021 Q3
15 quarters
|
|
|
HSII
340
DELISTED
Heidrick & Struggles
HSII
| $50.4M | 0.07% |
1,101,740
-49,200
| -4% | -$2.06M |
2013 Q2
48 quarters
|
|
341
Ferrari
RACE
$68.1B
| $50.4M | 0.07% |
102,876
-19,534
| -16% | -$9.08M |
2025 Q1
1 quarter
|
|
342
C.H. Robinson
CHRW
$16.5B
| $50.2M | 0.07% |
523,308
+180,400
| +53% | +$16.9M |
2024 Q3
3 quarters
|
|
343
Markel Group
MKL
$21.9B
| $50M | 0.07% |
25,011
-2,910
| -10% | -$5.46M |
2021 Q4
14 quarters
|
|
344
Freshworks
FRSH
$3.56B
| $49.8M | 0.07% |
3,337,200
+491,402
| +17% | +$7.08M |
2021 Q4
14 quarters
|
|
345
Ametek
AME
$56.7B
| $49.7M | 0.07% |
274,450
+243,900
| +798% | +$42M |
2021 Q3
15 quarters
|
|
346
Hormel Foods
HRL
$10.7B
| $49.5M | 0.07% |
1,636,225
-175,900
| -10% | -$5.31M |
2019 Q4
22 quarters
|
|
347
Patterson-UTI
PTEN
$4.38B
| $49.2M | 0.07% |
8,298,499
+3,480,500
| +72% | +$21M |
2024 Q3
3 quarters
|
|
348
Commerce Bancshares
CBSH
$7.83B
| $48.6M | 0.06% |
820,350
+160,125
| +24% | +$9.4M |
2022 Q3
11 quarters
|
|
349
Brookdale Senior Living
BKD
$2.6B
| $48.6M | 0.06% |
6,977,520
+730,418
| +12% | +$4.75M |
2017 Q4
30 quarters
|
|
350
W.W. Grainger
GWW
$59.8B
| $48.5M | 0.06% |
46,650
+18,450
| +65% | +$19.2M |
2021 Q3
15 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.